Table II.

Logistic regression analysis of factors that affect the expression of miR-130a, miR-25 and miR-191* in the serum of patients with non-small cell lung cancer.

							95% CI of Exp(B)
microRNA	Clinical characteristic	B	SE	Wald	P-value	Exp(B)	Lower	Upper
miR-130a	Radiotherapy	−1.228	0.533	5.315	0.021a	0.293	0.103	0.832
	Age	1.252	0.534	5.486	0.019a	3.496	1.227	9.963
	Radiotherapy	−1.268	0.570	4.948	0.026a	0.282	0.092	0.860
miR-25	Histological type	1.551	0.605	6.570	0.010a	4.715	1.440	15.431
	Survival status	−1.118	0.480	5.428	0.020a	0.327	0.128	0.837
miR-191*	Histological type	1.344	0.483	7.750	0.005b	3.836	1.489	9.884
	Radiotherapy	−1.326	0.537	6.101	0.014a	0.266	0.093	0.761
	Survival status	−1.034	0.511	4.097	0.043a	0.356	0.131	0.968

^aP<0.05

^bP<0.01. miR, microRNA; B, regression coefficient; SE, standard error; Exp(B) odds ratio.